marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-09-2022
Clovis Oncology Income Statement 2011-2024 | CLVS
Annual Income Statement Clovis Oncology
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
231 M | 697 M | 464 M | 1.28 B | 2.87 B | 2.38 B | 754 M | 2.21 B | 1.93 B | 491 M | 72.8 M |
Shares |
116 M | 88.3 M | 53.9 M | 52.1 M | 47 M | 38.5 M | 36 M | 33.9 M | 28.7 M | 24.9 M | 3.85 M |
Historical Prices |
2.04 | 7.9 | 8.29 | 25.4 | 60.5 | 64.8 | 20.9 | 65.2 | 65 | 19.7 | 19 |
Net Income |
-265 M | -369 M | -400 M | -368 M | -346 M | -349 M | -353 M | -160 M | -84.5 M | -74 M | -55.6 M |
Revenue |
149 M | 165 M | 143 M | 95.4 M | 55.5 M | 78 K | - | 13.6 M | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | 123 M | 108 M | 73.3 M | 43.8 M | 8 K | - | - | - | - | - |
Operating Income |
-226 M | -302 M | -377 M | -334 M | -238 M | -373 M | -377 M | -158 M | -83.8 M | -73.8 M | -54.6 M |
Interest Expense |
444 K | 1.36 M | 6.34 M | 7.92 M | 3.64 M | 633 K | 416 K | 2.6 M | -178 K | -228 K | -957 K |
EBITDA |
-217 M | -294 M | -360 M | -329 M | -235 M | -291 M | -299 M | -141 M | -82.9 M | -69.2 M | -39.4 M |
Operating Expenses |
- | 425 M | 476 M | 407 M | 281 M | 292 M | 300 M | 159 M | 83.1 M | 69.5 M | - |
General and Administrative Expenses |
128 M | 164 M | 183 M | 176 M | 139 M | 40.7 M | 30.5 M | 21.5 M | 16.6 M | 10.6 M | - |
All numbers in USD currency
Quarterly Income Statement Clovis Oncology
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 145 M | 144 M | 138 M | 129 M | 121 M | 108 M | 104 M | 96.7 M | 88.3 M | 80.5 M | 71.7 M | 54.8 M | 54.7 M | 53 M | 52.9 M | 52.7 M | 52.7 M | 52.2 M | 50.6 M | 50 M | 48.9 M | 45.2 M | 44 M | 38.6 M | 38.5 M | 38.4 M | 38.4 M | 38.3 M | 37.6 M | 34.1 M | 34 M | 33.9 M | 33.9 M | 33.9 M | 33.8 M | 31.8 M | 30 M | 26.7 M | 26 M | 25.9 M | 25.9 M | 25.7 M | 22 M | 11.5 M | 1.29 M | 1.29 M | 1.25 M |
Net Income |
- | -56 M | -71.3 M | -60.2 M | -64.4 M | -67.4 M | -66.4 M | -66.3 M | -99 M | -78.7 M | -92.2 M | -99.3 M | -99.5 M | -94.1 M | -120 M | -86.4 M | -99.3 M | -89.9 M | -101 M | -77.7 M | -51.9 M | -60.7 M | -175 M | -58.5 M | -70.7 M | -65.7 M | -129 M | -83.4 M | -120 M | -98.6 M | -71.5 M | -63.1 M | -54.9 M | -39.6 M | -34.8 M | -30.7 M | -29.2 M | -20.3 M | -19.3 M | -15.7 M | -21.1 M | -18.3 M | -15.7 M | -19 M | -14.9 M | -13.8 M | -18.5 M | -8.33 M |
Revenue |
- | 30.7 M | 32.1 M | 34.2 M | 36 M | 37.9 M | 36.8 M | 38.1 M | 43.3 M | 38.8 M | 39.9 M | 42.6 M | 39.3 M | 37.6 M | 33 M | 33.1 M | 30.4 M | 22.8 M | 23.8 M | 18.5 M | 17 M | 16.8 M | 14.6 M | 7.04 M | 78 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | 8.27 M | - | - | - | 9.1 M | - | - | - | - | - | 4.77 M | 4.49 M | 4.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | -44.2 M | -59.4 M | -50.4 M | -52.7 M | -57.5 M | -57.6 M | -58 M | -65 M | -72.5 M | -82.6 M | -82 M | -91.7 M | -106 M | -93.5 M | -85.2 M | -97 M | -89.2 M | -79 M | -68.7 M | -63.2 M | -60.5 M | -57.7 M | -56.2 M | -67.1 M | -64 M | -157 M | -85 M | -147 M | -97.3 M | -68.3 M | -64.2 M | -53.9 M | -41.1 M | -35 M | -28.5 M | -28.5 M | -20.4 M | -19.3 M | -15.6 M | -21.1 M | -18.2 M | -15.5 M | -19 M | -14.5 M | -13.3 M | -18.4 M | -8.45 M |
Interest Expense |
- | 192 K | 171 K | 148 K | 53 K | 101 K | 107 K | 183 K | 202 K | 79 K | 239 K | 841 K | 1.26 M | 781 K | 1.9 M | 2.4 M | 2.5 M | 2.54 M | 1.48 M | 1.41 M | 1.4 M | 1.29 M | 594 K | 354 K | 160 K | 252 K | 196 K | 25 K | 164 K | 179 K | 62 K | 11 K | 2.09 M | 511 K | -46 K | -46 K | -657 K | 55 K | -33 K | -78 K | -4 K | -48 K | -172 K | -4 K | -405 K | -555 K | -115 K | 118 K |
EBITDA |
- | -38.5 M | -55.6 M | -48.4 M | -52.7 M | -51 M | -53.1 M | -55.8 M | -65 M | -66.4 M | -78.5 M | -79.9 M | -91.7 M | -101 M | -89.8 M | -83.5 M | -97 M | -86.7 M | -77.5 M | -68.1 M | -63.2 M | -58.6 M | -56.5 M | -55.5 M | -67.1 M | -63.2 M | -156 M | -84.7 M | -147 M | -96.7 M | -68 M | -64.1 M | -53.9 M | -37.4 M | -31.4 M | -25 M | -28.5 M | -20.2 M | -19.2 M | -15.5 M | -21.1 M | -18 M | -15.3 M | -18.9 M | -14.5 M | -13.1 M | -18.3 M | -8.4 M |
Operating Expenses |
- | - | - | - | 88.7 M | 95.4 M | 94.4 M | 96.1 M | 108 M | 111 M | 123 M | 125 M | 131 M | 144 M | 126 M | 118 M | 127 M | 112 M | 103 M | 87.2 M | 80.2 M | 77.3 M | 72.4 M | 63.2 M | 67.2 M | 64 M | 157 M | 85 M | 147 M | 97.3 M | 68.3 M | 64.2 M | 53.9 M | 41.1 M | 35 M | 42.1 M | 28.5 M | 20.4 M | 19.3 M | 15.6 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | 30.4 M | 32.6 M | 29.2 M | 33.3 M | 32.2 M | 32.9 M | 29.9 M | 40.8 M | 38.6 M | 41.9 M | 42.6 M | 45.2 M | 41.8 M | 48 M | 47.8 M | 49.1 M | 42.5 M | 44.9 M | 39.3 M | 38.5 M | 35 M | 36.1 M | 29.2 M | 12.2 M | 9.16 M | 9.55 M | 9.83 M | 8.24 M | 8.33 M | 7.2 M | 6.75 M | 5.6 M | 5.27 M | 5.26 M | 5.32 M | 5.54 M | 4.31 M | 3.49 M | 3.22 M | 2.77 M | 2.76 M | 2.68 M | 2.42 M | 2.04 M | 1.71 M | 1.7 M | 1.4 M |
All numbers in USD currency